Biochemistry and clinical applications of ribavirin. - Wikidata - wikimedia - TriplyDB

Biochemistry and clinical applications of ribavirin.

Biochemistry and clinical applications of ribavirin.

http://www.wikidata.org/entity/Q39460438

about

Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesis RNA virus error catastrophe: direct molecular test by using ribavirin Respiratory viruses other than influenza virus: impact and therapeutic advances Synergistic anti-influenza virus A (H1N1) activities of PM-523 (polyoxometalate) and ribavirin in vitro and in vivo Analysis of Ribavirin Mutagenicity in Human Hepatitis C Virus Infection Counteracting Quasispecies Adaptability: Extinction of a Ribavirin-Resistant Virus Mutant by an Alternative Mutagenic Treatment Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds Ribavirin antagonizes the effect of azidothymidine on HIV replication Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections New aspects of influenza viruses.MegaRibavirin aerosol for the treatment of influenza A virus infections in mice Recent progress in antiviral chemotherapy for respiratory syncytial virus infections.Treatment of human immunodeficiency virus infections Aerosolized amphotericin B-liposomes for treatment of systemic Candida infections in mice.Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus.Recent advances in diagnosis and therapy of human papillomaviruses.Neuroprotection and reduced proliferation of microglia in ribavirin-treated bornavirus-infected rats.Antiviral therapy: respiratory infections, chronic hepatitis.Inhibition of respiratory syncytial virus fusion by the small molecule VP-14637 via specific interactions with F protein.Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells Identification of AP80978, a novel small-molecule inhibitor of hepatitis C virus replication that targets NS4B.Pharmacokinetics of ribavirin aerosol in mice Safety, tolerance, and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection.In search of a small-molecule inhibitor for respiratory syncytial virus.Antisense approaches for inhibiting respiratory syncytial virus.Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review Management of respiratory viral infections in hematopoietic cell transplant recipients.ITPA gene polymorphisms significantly affect hemoglobin decline and treatment outcomes in patients coinfected with HIV and HCV.Anti-influenza virus agents: synthesis and mode of action.Aerosol and intraperitoneal administration of ribavirin and ribavirin triacetate: pharmacokinetics and protection of mice against intracerebral infection with influenza A/WSN virus.Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice A novel benzo-heterocyclic amine derivative N30 inhibits influenza virus replication by depression of Inosine-5'-Monophospate Dehydrogenase activity.Viral pneumonias in immunocompromised adult hosts.Economic and long-term benefits of ribavirin therapy on respiratory syncytial virus infection.Aerosols for systemic treatment.Perspectives in antiviral chemotherapy.The paramyxovirus polymerase complex as a target for next-generation anti-paramyxovirus therapeutics.Structure-guided design of small-molecule therapeutics against RSV disease.

P2860

Q21132564-DD100B0B-73D5-4FEC-80D5-BFD39EA2393B Q24599371-89F9484A-1DC2-4803-86DD-DE8D0C4E582E Q24655957-E5ECA582-66B1-4D6C-AF0A-1D03F67175BA Q27477604-83DF1286-8AAB-4187-A9D8-246489DD7945 Q27480933-CAA54B41-7B17-45D3-8C85-E57558E077A6 Q27488361-F47E69F9-F428-4908-AA15-4C018BCDE29A Q28328538-37C9FFFC-B0B9-4DB9-A3DD-061FE484A9FF Q28337829-8788A2F4-1305-4EE6-839D-582209A11607 Q28344042-FC977E21-BE86-4297-BBE9-7E37C1924759 Q28361577-E86F9A33-8260-4FA0-B587-93FA55F8CB51 Q28471847-6AA94262-7B46-4424-92FB-23EED589B326 Q30333613-CFB9E07E-6249-4F44-B757-DBDB93E5972D Q30367819-57BDBB3C-FFE6-4936-B4D2-26244E1D65A3 Q31521336-8109CD09-8AE5-42CD-B0AE-F5672DD55CAA Q33740357-05B1877F-548F-4A4B-B7EF-F9DAF7CF7DC8 Q33749615-D7DA71C7-AEB5-44E1-B1D7-657E0BA822A7 Q33852451-94E7004B-55C9-4DD9-B650-8A336C5A6EA8 Q34074998-B9CC342D-587B-49BC-8386-F1035B9C937A Q34109709-45DBB75F-0F63-4447-9387-F2695DCCB4D3 Q34344409-78019800-71A0-4153-B474-A55A710AFBDB Q34975477-B8C6D38B-5BA0-44FC-8E34-425CF6BE4C29 Q34976911-BB419660-126C-43F8-850E-C161AE8CD7D0 Q35141547-BE6FAE48-45BC-4521-9597-5899EDA554FD Q35289449-7026516D-AD33-42C3-8142-7097D6E0296D Q35810419-BBC38046-3E0A-4871-AEBE-AF3D47A49109 Q35917503-EC33B499-BBEA-436D-BA7E-6C8491A8927A Q36065956-C78CB601-6C08-4BA6-88E0-8BC7FD112C11 Q36386176-650CB0C3-490E-461F-9E36-A7C1BC3650C8 Q36439896-0E6F1EE0-C0B7-4F6E-A5C7-8C5AFBDE8677 Q36457789-4770FF9B-E7A6-43C9-8E57-30220CF34145 Q36679637-336F0D03-F724-49A2-9812-E36A847215C8 Q36754241-D3553855-DAA5-4DBC-A0DC-E65156CD5706 Q36949482-6E6BB4D3-0D23-44FF-8248-3EA94BBEF08C Q37704838-2D6E365D-8CA3-4812-9EE5-93F783D5FBE2 Q37788451-EC764FB1-4D43-463C-A506-71A5EDDCCFA1 Q37822416-6AF38B7D-660C-4A39-BEB9-B40DEC86B19A Q37822444-DCE79634-4867-4DA8-9A7B-DFCA8C661E51 Q37959377-6DE2ABF8-E576-4244-8AFC-3D085B2A84AD Q38510112-4BA15890-438A-4C6A-A5A6-5BDA04D9A488 Q38798541-DE4D17C4-5D48-4785-BFE8-46CC9940515B

P2860

Biochemistry and clinical applications of ribavirin.

http://www.wikidata.org/entity/Q39460438

description

1986 nî lūn-bûn

@nan

1986年の論文

@ja

1986年論文

@yue

1986年論文

@zh-hant

1986年論文

@zh-hk

1986年論文

@zh-mo

1986年論文

@zh-tw

1986年论文

@wuu

1986年论文

@zh

1986年论文

@zh-cn

name

Biochemistry and clinical applications of ribavirin.

@en

Biochemistry and clinical applications of ribavirin.

@nl

type

label

Biochemistry and clinical applications of ribavirin.

@en

Biochemistry and clinical applications of ribavirin.

@nl

prefLabel

Biochemistry and clinical applications of ribavirin.

@en

Biochemistry and clinical applications of ribavirin.

@nl

P1433

Q39460438-95F1E72F-A8BF-4264-9F80-F5EE2705860D

P1476

Q39460438-5C4F6CF8-1449-44F1-9AAA-A87653DFEC67

P2093

Q39460438-AED14896-5BCC-401B-BB3C-67469A2D5C2D

Q39460438-D99421AB-9A6B-4D66-857F-14E71B7007FA

P2860

Q39460438-06C6AE5B-5DF2-4FE0-B164-0F2DEED8A825

Q39460438-0B6B5E98-ABF2-43DA-A8E0-C2D6D7BE3C48

Q39460438-1AE5F210-CF47-4F2F-82F6-8BEBC67BEE74

Q39460438-36989510-C62B-4F06-A6AD-0E7AC0FAC6F1

Q39460438-40C1AE87-EAE1-4854-A783-9F0F685CE0D4

Q39460438-4118DBA2-509D-4425-9293-EE2B6401EA91

Q39460438-452095C5-A5D7-4280-857D-88CF11316DAD

Q39460438-57DFC7B2-AAE9-40C6-A436-1877097E49DA

Q39460438-64F37505-F08E-4306-BE62-E14DF7A38088

Q39460438-678F8AC1-F6E2-4F59-982C-D33A1B93B5E0

P304

Q39460438-C81904BA-327C-4E2B-BB82-6B0E46AE089A

P31

Q39460438-4F158C52-4878-493E-BA98-7B2C99EC765F

P356

Q39460438-3F896B76-DC5E-457C-A41F-11C337DCA331

P407

Q39460438-EC170C53-B4C3-4DF9-9E8D-B75327FA35E0

P433

Q39460438-8AAC6A52-1FA2-47B6-B14B-9B86360D9E9A

P478

Q39460438-82453359-62C1-4EA6-9F34-766BFF555B44

P577

Q39460438-DA78216C-D8E0-4FA1-B4CB-9EF5542CC070

P5875

Q39460438-8AA1CB9C-51A8-435E-A413-E700B96B335B

P698

Q39460438-2D37DCFF-74DE-4475-9AA3-67F613806A05

P932

Q39460438-27E224C5-3903-4690-8C0B-7F4C1F3A9C8A

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Biochemistry and clinical applications of ribavirin.

@en

P2093

Gilbert BE

http://www.w3.org/2001/XMLSchema#string

Knight V

http://www.w3.org/2001/XMLSchema#string

P2860

Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent

Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice

In vivo inhibition of respiratory syncytial virus by ribavirin

Treatment of influenza A (H1N1) virus infection with ribavirin aerosol

Lassa fever. Effective therapy with ribavirin

Therapeutic effects of ribavirin given by the intraperitoneal or aerosol route against influenza virus infections in mice.

Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent

Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84.

Plasma disappearance, urine excretion, and tissue distribution of ribavirin in rats and rhesus monkeys

Lack of interference of guanosine with ribavirin aerosol treatment of influenza A infection in mice.

P304

201-205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.30.2.201

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

1986-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20278935

http://www.w3.org/2001/XMLSchema#string

P698

2876677

http://www.w3.org/2001/XMLSchema#string

P932

180518

http://www.w3.org/2001/XMLSchema#string